Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Boffito

Showing results (31-40 of 300) with videos related to

Pageof 30
Sort By:
Journal of HIV Therapy|September 3, 2003
Antiretroviral therapy to reduce the sexual transmission of HIVStephen Taylor, Marta Boffito, Pietro L Vernazza
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
The clinical pharmacology of antiretrovirals in developmentAlan Winston, Patrick Wg Mallon, Marta Boffito
The Lancet. HIV|February 7, 2020
Antiretroviral resistance and management after pre-exposure to prophylaxisVictoria Tittle, Marta Boffito, Alan McOwan, et al.
AIDS (London, England)|December 1, 2021
Pharmacokinetic interactions of modern antiretroviral therapyPhumla Z Sinxadi, Saye H Khoo, Marta Boffito
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2011
Should we switch to a 50-mg boosting dose of ritonavir for selected protease inhibitors?Andrew Hill, Saye Khoo, Marta Boffito, et al.
Journal of Virus Eradication|February 18, 2021
The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIVLaura Waters, Viraj Mehta, Jaideep Gogtay, et al.
Drugs|December 12, 2013
New approaches to antiretroviral drug delivery: challenges and opportunities associated with the use of long-acting injectable agentsMarta Boffito, Akil Jackson, Andrew Owen, et al.
Clinical Pharmacokinetics|October 22, 2014
Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesVictoria Tittle, Lauren Bull, Marta Boffito, et al.
Current Opinion in HIV and AIDS|June 2, 2017
Antiretroviral dose optimization: the future of efavirenz 400 mg dosingMarta Boffito, Mohammed Lamorde, Melynda Watkins, et al.
Current Opinion in Infectious Diseases|January 14, 2005
The pharmacokinetics of HIV protease inhibitor combinationsMarta Boffito, Desmond Maitland, Yohan Samarasinghe, et al.
Pageof 30

Showing results (31-40 of 300) with videos related to

Sort By:
Pageof 30
Journal of HIV Therapy|September 3, 2003
Antiretroviral therapy to reduce the sexual transmission of HIVStephen Taylor, Marta Boffito, Pietro L Vernazza
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
The clinical pharmacology of antiretrovirals in developmentAlan Winston, Patrick Wg Mallon, Marta Boffito
The Lancet. HIV|February 7, 2020
Antiretroviral resistance and management after pre-exposure to prophylaxisVictoria Tittle, Marta Boffito, Alan McOwan, et al.
AIDS (London, England)|December 1, 2021
Pharmacokinetic interactions of modern antiretroviral therapyPhumla Z Sinxadi, Saye H Khoo, Marta Boffito
Journal of Acquired Immune Deficiency Syndromes (1999)|November 15, 2011
Should we switch to a 50-mg boosting dose of ritonavir for selected protease inhibitors?Andrew Hill, Saye Khoo, Marta Boffito, et al.
Journal of Virus Eradication|February 18, 2021
The evidence for using tenofovir disoproxil fumarate plus lamivudine as a nucleoside analogue backbone for the treatment of HIVLaura Waters, Viraj Mehta, Jaideep Gogtay, et al.
Drugs|December 12, 2013
New approaches to antiretroviral drug delivery: challenges and opportunities associated with the use of long-acting injectable agentsMarta Boffito, Akil Jackson, Andrew Owen, et al.
Clinical Pharmacokinetics|October 22, 2014
Pharmacokinetic and pharmacodynamic drug interactions between antiretrovirals and oral contraceptivesVictoria Tittle, Lauren Bull, Marta Boffito, et al.
Current Opinion in HIV and AIDS|June 2, 2017
Antiretroviral dose optimization: the future of efavirenz 400 mg dosingMarta Boffito, Mohammed Lamorde, Melynda Watkins, et al.
Current Opinion in Infectious Diseases|January 14, 2005
The pharmacokinetics of HIV protease inhibitor combinationsMarta Boffito, Desmond Maitland, Yohan Samarasinghe, et al.
Pageof 30